✦ LIBER ✦

1095 Pharmacogenomic analysis of the triplet combination of gemcitabine, oxaliplatin and cetuximab as salvage therapy for metastatic colorectal cancer (mCRC) patients

✍ Scribed by E. Bandres; J. Rodriguez; A. Hernandez; N. Bitarte; N. Ramirez; J.A. Diaz-Gonzalez; A. Chopitea; M. Ponz; R.N. Zarate; J. Garcia-Foncillas

Book ID: 119600149
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 49 KB
Volume: 7
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(09)70388-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment outcomes of oxaliplatin, 5-FU,

Treatment outcomes of oxaliplatin, 5-FU, and leucovorin as salvage therapy for patients with advanced or metastatic gastric cancer: a retrospective analysis

✍ Hee Yeon Seo; Dae Sik Kim; Yoon Seok Choi; Hwa Jung Sung; Kyong Hwa Park; In Keu 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 290 KB

EC3 COST-MINIMIZATION ANALYSIS OF CAPECI

EC3 COST-MINIMIZATION ANALYSIS OF CAPECITABINE + OXALIPLATIN (XELOX) VS. INFUSIONAL 5-FU/LV + OXALIPLATIN (FOLFOX-6) AS FIRST-LINE TREATMENT FOR METASTATIC COLORECTAL CANCER (MCRC) IN THE FRENCH SETTING

✍ G Perrocheau; M Ducreux; M Hebbar; M Ychou; G Lledo; T Conroy; R Faroux; JY Doui 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

6077 A meta-analysis of the CRYSTAL and

6077 A meta-analysis of the CRYSTAL and OPUS studies combining cetuximab with chemotherapy (CT) as 1st-line treatment for patients (pts) with metastatic colorectal cancer (mCRC): Results according to KRAS and BRAF mutation status

✍ Van Cutsem, E.; Rougier, P.; Köhne, C.; Stroh, C.; Schlichting, M.; Bokemeyer, C 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB

6137 POSTER Biological Analysis of Phase

6137 POSTER Biological Analysis of Phase II Study Evaluating the Activity of Cetuximab Combined to Oxaliplatin and Fluoropirimidine (TEGAFOX-E) as First Line Treatment in Metastatic Colorectal Cancer (mCRC) Pts by the Italian Trials in Medical Oncology (I.T.M.O.) Group

✍ Bartolomeo, M. Pi; Dotti, K.F.; Pietrantonio, F.; Perrone, F.; Martinetti, A.; P 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Cetuximab Plus Capecitabine and Irinotec

Cetuximab Plus Capecitabine and Irinotecan Compared With Cetuximab Plus Capecitabine and Oxaliplatin As First-Line Treatment for Patients With Metastatic Colorectal Cancer: AIO KRK-0104--A Randomized Trial of the German AIO CRC Study Group

✍ Moosmann, N.; von Weikersthal, L. F.; Vehling-Kaiser, U.; Stauch, M.; Hass, H. G 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 169 KB

4004 Cetuximab plus capecitabine as firs

4004 Cetuximab plus capecitabine as first-line treatment for elderly patients (pts) with advanced colorectal cancer (mCRC). Final analysis of activity and survival according to KRAS status – the TTD-06–01 Spanish Cooperative Group trial

✍ F. Rivera; C. Gravalos; B. Massutí; J. Puente; E. Marcuello; M. Valladares; V. G 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB